Cargando…
Imidazole-4-N-acetamide Derivatives as a Novel Scaffold for Selective Targeting of Cyclin Dependent Kinases
SIMPLE SUMMARY: General toxicity for the organism is a major drawback of anticancer drugs. Development of new generation chemotherapeutics requires the knowledge about macromolecules critical for tumor cell viability. Among these species (called therapeutic targets), the protein kinases are the esta...
Autores principales: | Rusina, Polina, Gandalipov, Erik, Abdusheva, Yana, Panova, Maria, Burdenkova, Alexandra, Chaliy, Vasiliy, Brachs, Maria, Stroganov, Oleg, Guzeeva, Ksenia, Svitanko, Igor, Shtil, Alexander, Novikov, Fedor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417023/ https://www.ncbi.nlm.nih.gov/pubmed/37568583 http://dx.doi.org/10.3390/cancers15153766 |
Ejemplares similares
-
Lung Fibrosis after COVID-19: Treatment Prospects
por: Bazdyrev, Evgeny, et al.
Publicado: (2021) -
The Hidden Pandemic of COVID-19-Induced Organizing Pneumonia
por: Bazdyrev, Evgeny, et al.
Publicado: (2022) -
Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial
por: Bazdyrev, Evgeny, et al.
Publicado: (2022) -
Inhibition of SYK and cSrc kinases can protect bone and cartilage in preclinical models of osteoarthritis and rheumatoid arthritis
por: Novikov, F. N., et al.
Publicado: (2021) -
Author Correction: Inhibition of SYK and cSrc kinases can protect bone and cartilage in preclinical models of osteoarthritis and rheumatoid arthritis
por: Novikov, F. N., et al.
Publicado: (2022)